Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses’ Health Studies
Open Access
- 1 December 2018
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 4 (12) , 1675-1682
Abstract
Ovarian cancer is the fifth most common cause of cancer-related death among women in the United States.1 There is growing evidence to support a role for inflammation in the development of ovarian cancer.2-6 Localized inflammation, as occurs with ovulation, may contribute to ovarian tumorigenesis,2 and epidemiologic studies have consistently observed positive associations between a higher number of lifetime ovulatory cycles and risk of ovarian cancer.7-10 Systemic inflammation has also been associated with increased risk of ovarian cancer. For example, meta-analyses of studies of circulating C-reactive protein, a marker of systemic inflammation, reported a nearly 2-fold increased risk of ovarian cancer for those with high vs low C-reactive protein levels.6,11Keywords
This publication has 38 references indexed in Scilit:
- The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findingsInflammopharmacology, 2013
- Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic reviewCancer Causes & Control, 2012
- Symptoms Associated With Ovarian CancerClinical Obstetrics and Gynecology, 2012
- Nonsteroidal Anti-Inflammatory Drugs and Risk for Ovarian and Endometrial Cancers in the Iowa Women's Health StudyCancer Epidemiology, Biomarkers & Prevention, 2010
- Use of Nonsteroidal Antiinflammatory Agents and Incidence of Ovarian Cancer in 2 Large Prospective CohortsAmerican Journal of Epidemiology, 2009
- Markers of inflammation and risk of ovarian cancer in Los Angeles CountyInternational Journal of Cancer, 2008
- Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studiesAmerican Journal of Obstetrics and Gynecology, 2007
- Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogeneticsNature Reviews Cancer, 2006
- Non-Narcotic Analgesic Dose and Risk of Incident Hypertension in US WomenHypertension, 2005
- Ovulation and risk of epithelial ovarian cancerInternational Journal of Cancer, 2003